A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
Article in Cancers (April 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Targeting senescence as a therapeutic opportunity for triple-negative breast cancer
Article in Molecular Cancer Therapeutics (February 2023)
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
Article in BMC Cancer (October 2022)